• Tue, November 26, 2013
  • Fri, November 29, 2013
  • Mon, December 2, 2013
  • Wed, November 27, 2013
  • Tue, December 3, 2013
  • Wed, December 4, 2013
  • Thu, December 5, 2013
  • Fri, December 6, 2013

Christopher Raymond Initiated (BMRN) at Buy on, Nov 26th, 2013

Christopher Raymond of Piper Sandler, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy on, Nov 26th, 2013.

Christopher has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $85 on, Thursday, September 5th, 2013


Similar Stocks and Investing Publications